← Leaderboards
Michael J Yost
University Of South Carolina At Columbia
$2,733,135
Attributed
$3,337,823
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $405.8K · FY2005–21$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,337,823 · 3
By mechanism
R01$2,639,603 · 2
K25$698,220 · 1
Top collaborators
- Stephen Tomlinson2 shared
- Carl Atkinson1 shared
Most similar at University Of South Carolina At Columbia
Same institution · by research overlap
- Nicole Zieber$1,009,039
- Julia Rose Yurkovic-Harding$78,520
Others in their field
Top investigators on “Fibroblasts”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$57,068,242
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$37,747,421
- Joseph C Wu · Stanford University$36,488,088
- Kristin Ardlie · Genomics Collaborative, Inc.$34,108,405
- Gail V Anderson · La Biomed Res Inst/ Harbor Ucla Med Ctr$27,497,410
- Joseph E Robertson · Oregon Health & Science University$27,496,135
Research focus
FibroblastsTissue EngineeringCollagenInflammationHuman BodyImplantationOperative Surgical ProceduresEngraftmentMuscleHealingAffectBioengineering /Biomedical EngineeringDefectImplantInflammatory ResponseMass Tissue /Cell CultureDesignEngineeringCicatrixMediatingAutologousForeign BodiesCellsPeptides
Grant awards (12)
Cell survival in engineered skeletal muscle: The role of complement$397,714
R01 · FY2021 · EB · contact PI
Cell survival in engineered skeletal muscle: The role of complement$405,831
R01 · FY2020 · EB · contact PI
Cell survival in engineered skeletal muscle: The role of complement$405,831
R01 · FY2019 · EB · contact PI
An Enabling Technology for Improving Engraftment of Implanted Materials and Cells$346,655
R01 · FY2013 · DE · contact PI
An Enabling Technology for Improving Engraftment of Implanted Materials and Cells$378,912
R01 · FY2012 · DE · contact PI
An Enabling Technology for Improving Engraftment of Implanted Materials and Cells$342,410
R01 · FY2011 · DE · contact PI
An Enabling Technology for Improving Engraftment of Implanted Materials and Cells$362,250
R01 · FY2010 · DE · contact PI
Tissue Engineered Artificial Myocardium$139,644
K25 · FY2005 · HL
Tissue Engineered Artificial Myocardium$139,644
K25 · FY2004 · HL
Tissue Engineered Artificial Myocardium$139,644
K25 · FY2003 · HL
Tissue Engineered Artificial Myocardium$139,644
K25 · FY2002 · HL
Tissue Engineered Artificial Myocardium$139,644
K25 · FY2001 · HL